Regulatory Action Initiated Against Top Executives of Tigermed

Stock News

May 12

Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a "Case Filing Notice" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1189856154"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189856154\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189856154?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189856154","market":"nz","top_or_hot":-1,"title":"Regulatory Action Initiated Against Top Executives of Tigermed","media":"Stock News","content":"<p>Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regulatory Action Initiated Against Top Executives of Tigermed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegulatory Action Initiated Against Top Executives of Tigermed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-12 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1189856154","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189856154","pubTimestamp":1778594619,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300347":"泰格医药","BK1141":"生命科学工具和服务","BK0028":"国家队","BK1583":"高瓴概念","BK1576":"医药外包概念","03347":"泰格医药","BK0216":"研究试验","LU1146622755.USD":"安本中国A股股票基金A Acc","BK0174":"增持","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","BK0077":"质押式回购"},"translate_title":"对泰格医药高管发起监管行动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300347":1,"03347":1},"content_text":"Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}